← FDA Drug Approvals (Drugs@FDA)

NITROFURANTOIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2023-05-11

Drug application

FDA Application #

ANDA212607

Application type

Abbreviated New Drug Application (Generic)

Brand name

NITROFURANTOIN

Generic name

NITROFURANTOIN

Active ingredients

NITROFURANTOIN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA

Manufacturer

Rising Pharma Holdings, Inc.

First approval

2023-05-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown